.-We have previously shown that exposure to diesel exhaust particles (DEPs) stimulates human airway epithelial cells to secrete the inflammatory cytokines interleukin-8, interleukin-1␤, and granulocyte-macrophage colony-stimulating factor (GM-CSF) involved in allergic diseases. In the present paper, we studied the mechanisms underlying the increase in GM-CSF release elicited by DEPs using the human bronchial epithelial cell line 16HBE14oϪ. RT-PCR analysis has shown an increase in GM-CSF mRNA levels after DEP treatments.
more prominent in recent decades so that 30% of the population in some communities may manifest atopic diseases. Indeed, a number of carefully controlled studies point to a real rise in the frequency of asthma in developed communities (40) . The recent and rapid rise in asthma emphasizes the importance of environmental factors for the development of atopy and asthma. Among the environmental factors, traffic-related air pollution should be considered, in particular diesel exhaust. Indeed, the number of diesel engine-powered cars has been increasing steadily in recent years, and they are one of the major causes of air pollution in urban areas. Diesel exhaust particles (DEPs) aggregate to form agglomerates of ϳ0.1-0.5 µm, which are of respirable size. DEPs are composed of a carbon core that adsorbs trace amounts of heavy metals and a great number of organic compounds that could represent up to 40% of the particle (39) . Until now, it is unclear which component of DEPs is involved in the biological effects: the carbon core, the adsorbed organic compounds, or, as in asbestos or residual oil fly ash (ROFA), the metals present on the particle surface.
Recent studies have emphasized the role of DEPs in the development of an inflammatory response. It has been shown that DEPs instilled intratracheally in mice induce asthmalike symptoms (30) and have an adjuvant activity for IgE production (21) . DEP exposure also induces hyperresponsiveness to histamine in guinea pigs (19) or to acetylcholine in combination with ovalbumin in mice (22) . Nasal challenges of human beings with DEPs result in the local increase in IgE and cytokine production (13, 14) . Moreover, there is increasing evidence that airway epithelial cells play an active role in allergic inflammation. Besides the function as a physical barrier, the airway epithelium could release a variety of cytokines such as interleukin (IL)-1, IL-6, IL-8, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor (GM-CSF) that are relevant to allergic airway inflammation (1) . Because the epithelium is one of the first targets of inhaled DEPs, it could therefore be a plausible initial mediator of allergic inflammation. Indeed, Boland et al. (6) have previously shown that in vitro DEPs induce an increase in the release of the proinflammatory cytokines IL-8, IL-1␤, and GM-CSF by human airway epithelial cells. Among these cytokines, GM-CSF is a crucial cytokine for the maturation of granulocytes and
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macrophages as well as of eosinophils. It also increases the eosinophil survival rate and stimulates Langerhans cell activation (37) . The stimulation of cytokine secretion could be due to the release of preexisting pools of cytokines or to de novo protein synthesis. Increased cytokine secretion by various agents often involves mRNA stability or enhanced transcription of cytokine genes. Transcription factors such as activator protein-1 and nuclear factor-B (NF-B) are known to be involved in the upregulation of many cytokines including GM-CSF. Their activation is dependent on signaling cascades involving protein phosphorylation and/or reactive oxygen species (ROS). In a previous paper, BaezaSquiban et al. (3) have demonstrated an increased binding of NF-B to DNA after DEP but not after carbon black exposure of bronchial epithelial cells (16HBE14oϪ).
The aim of this study was to elucidate the underlying molecular and cellular mechanisms of this enhanced GM-CSF release induced by DEPs. A key question is the relative importance of the nonextractable DEP core versus adsorbed organic compounds, which led us to compare the effects of nonextracted and extracted DEPs (SRM 1650) as well as the effects of extracts of DEPs. We also raised the question whether the native DEPs containing the adsorbed organic compounds have to be endocytosed to induce an increase in GM-CSF release. Because signaling cascades involved in the regulation of cytokine production can imply ROS and protein phosphorylation, we evaluated in the present study the contribution of ROS and protein kinases in the regulation of DEP-mediated GM-CSF release by the use of specific inhibitors.
MATERIALS AND METHODS
Culture conditions. Dr. D. C. Gruenert (Cardiovascular Research Institute, University of California, San Francisco, CA) kindly provided the human bronchial epithelial cell subclone 16HBE14oϪ, the properties of which have been previously described (11) . The cell line was maintained routinely at the logarithmic phase of growth through subculturing once a week, and experiments were performed at passages . Cells were cultured on collagen (type I, 4 µg/cm 2 ; Sigma, Saint Quentin Fallavier, France)-coated 25-or 75-cm 2 flasks or 6-well plates at 20,000 cells/cm 2 in Dulbecco's modified Eagle's medium-Ham's F-12 medium nutrient mixture (DMEM-F-12; 1:1; GIBCO BRL, Life Technologies, Cergy Pontoise, France) supplemented with antibiotics (100 U/ml of penicillin and 100 µg/ml of streptomycin; Sigma), Fungizone (1 µg/ml; GIBCO BRL), and 10% fetal bovine serum (GIBCO BRL). The culture medium was changed every 2 days, and the serum was removed 24 h before treatments. The cultures were incubated in humidified 95% air with 5% CO 2 at 37°C.
Reagents. The diesel particulate matter SRM 1650 was purchased from the National Institute of Standards and Technology (Gaithersburg, MD). Carbon black (FR103; 95-nm diameter) was obtained from Degussa (Frankfurt, Germany). Cytochalasin D (Cyto D; Sigma) was used at 10 µg/ml, actinomycin D (Sigma) was used at 0.2 µg/ml, H-89 (ICN, Orsay, France) at 5 µM, GF-109203X (Sigma) was used at 5 µM, genistein (Sigma) was used at 75 µM, nordihydroguaiaretic acid (Sigma) was used at 10 µM, PD-98059 (Tebu, le Perray-en-Yvelines, France) was used at 10 µM, and SB-203580 (Calbiochem, Meudon, France) was used at 1 µM. Stock solutions of these reagents were prepared in dimethyl sulfoxide (DMSO) and stored at Ϫ20°C. Pyrrolidinedithiocarbamate (PDTC; Sigma) was used at 5 µM, ␣-tocopherol (Sigma) was used at 0.1 mM, and indomethacin (Sigma) was used at 10 µM. Stock solutions of these reagents were prepared in ethanol and stored at Ϫ20°C. Cycloheximide (Sigma) at 10 µg/ml, N-acetyl-L-cysteine (NAC; Sigma) at 10 mM (pH 7.4), 1,3-dimethyl-2-thiourea (DMTU; Sigma) at 10 mM, and desferrioxamine (DEF; Ciba-Geigy, Rueil-Malmaison, France) at 0.1 mM were prepared in culture medium and stored at Ϫ20°C. The final concentration of ethanol or DMSO in the culture medium did not exceed 0.1%. MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assays after 4 or 24 h of treatment with these inhibitors and scavengers showed no cytotoxicity at these concentrations.
Chemical treatment. Stock solutions of particles were performed by suspension in a solution of 0.04% dipalmitoyl lecithin (Sigma) in distilled water and sonicated three times for 60 s each at maximal power (8 kilocycles). DEPs were extracted by dichloromethane in a Soxhlet apparatus, and the extract was dried and redissolved in DMSO. The recovered particles were extracted a second time to ensure total extraction. Particles were sonicated three times for 20 s each just before addition to the cultures, and dipalmitoyl lecithin was added to control cultures as well as DMSO in the experiments with extracts of DEPs. Concentrations are expressed in micrograms per square centimeter because the particles rapidly sediment onto the culture. Inhibitors or scavengers were added 30 min before DEP treatment.
Cytokine assay. Four-day-old cultures were treated with particles at 10 µg/cm 2 , and after 24 h of treatment, the culture supernatant was centrifuged and the samples were frozen at Ϫ80°C until used. The concentration of GM-CSF released into the culture supernatant was measured with human GM-CSF ELISA kits (Amersham, Les Ulis, France). Briefly, the GM-CSF present in the culture supernatant reacts with mouse monoclonal antibodies against GM-CSF bound to the wells of a microtiter plate. A monospecific antibody to GM-CSF conjugated to horseradish peroxidase reacts with the GM-CSF bound to the monoclonal antibody. Any unbound protein was washed away, and color development after addition of the enzyme substrate was measured at 450 nm with a Microplate Photometer MRX 5000 (Dynatech Laboratories). The concentration of GM-CSF in the culture supernatant was determined with a standard curve established with the use of a human recombinant GM-CSF.
Detection of GM-CSF mRNA by RT-PCR. The oligonucleotides used for PCR were chosen to encompass at least one intron to detect amplification of contaminating genomic DNA. For GM-CSF, the primers were sense, 5Ј-GGC GTC TCC TGA ACC TGA GTA G-3Ј, and antisense, 5Ј-GTC GGC TCC TGG AGG TCA AA-3Ј(size of the amplified products was 91 bp). For the ribosomal protein S14, used as the standard, the primers were sense, 5Ј-ATC AAA CTC CGG GCC ACA GGA-3Ј, and antisense, 5Ј-GTG CTG TCA GAG GGG ATG GGG-3Ј(137 bp).
Total cellular RNA was isolated from 16HBE14oϪ cultures with TRIzol Reagent (GIBCO BRL) according to Chomczynski and Sacchi (10) . Purified RNA was dissolved in RNasefree water and quantified by measurement of absorbance at 260 nm. All samples were demonstrated to contain undegraded RNA as assessed by electrophoresis of an aliquot of each preparation on 1% agarose gels and visualization of the products after ethidium bromide staining. One microgram of total RNA was first incubated for 5 min at 70°C with 1 µg of oligo(dT) in a volume of 7.5 µl and quick-chilled on ice before RT reaction buffer was added. Single-strand cDNA synthesis was carried out in 12.5 µl containing 50 mM Tris · HCl (pH 8.5), 30 mM KCl, 8 mM MgCl 2 , 1 mM dithiothreithol, 1 mM deoxynucleotide triphosphates, 25 U of RNase inhibitor, and 40 U of avian myeloblastosis virus reverse transcriptase (Boehringer Mannheim, Meylan, France). The reaction mixture was incubated for 60 min at 42°C and then for 5 min at 99°C. cDNA was amplified in 50 µl of reaction buffer containing 50 mM KCl, 20 mM Tris (pH 8.4), 2 mM (for S14) or 1.5 mM (for GM-CSF) MgCl 2 , 0.2 mM deoxynucleotide triphosphates, and 0.24 µM each primer. Samples were heated to 80°C before 2.5 U of Taq polymerase (Life Technologies) were added to reduce formation of nonspecific amplification products. Cycling parameters were as follows: denaturation, 94°C for 1 min; annealing, 59 (for S14) or 55°C (for GM-CSF) for 1 min; and extension, 72°C for 1 min. The final extension was carried out for 5 min. Amplification products were analyzed by electrophoresis on 2% agarose gels and visualized by ethidium bromide staining.
Western blotting. Levels of phosphorylated and nonphosphorylated extracellular signal-regulated kinase (ERK) 1/2 in control and DEP-treated cells were determined by SDS-PAGE as described previously (20) . Briefly, proteins were collected from pelleted cells by resuspension in Laemmli buffer, pH 7.4 (0.06 M Tris, 3% SDS, 5% ␤-mercaptoethanol, and 10% glycerol) with 1 mM phenylmethylsulfonyl fluoride and run on 12% SDS-PAGE gels. Samples were normalized for protein content before being loaded. Electrophoresed proteins were electroblotted onto nitrocellulose membrane, and the blots were blocked with 5% milk in Tris-buffered saline (0.02 M Tris and 0.135 M NaCl, pH 7.6) containing 0.1% Tween. They were incubated overnight with the primary antibody and 1% milk in Tris-buffered saline-0.1% Tween. Horseradish peroxidase-conjugated anti-rabbit IgG was used as secondary antibody. Bands were detected with chemiluminescence reagents and film as per the manufacturer's instructions (NEN, Les Ulis, France).
Statistical analysis. Student's t-test was used to compare cytokine secretion from control versus treated samples. Values are means Ϯ SE. P values were corrected for multiple comparisons.
RESULTS
16HBE14oϪ cells cultured in the presence of DEPs produced a time-and dose-dependent increase in GM-CSF release (Fig. 1) , which was already significant from 5 µg/cm 2 after 24 h of exposure (108.2. Ϯ 0.8 pg/ml compared with 57.1 Ϯ 2.4 in control cells).
To investigate whether the DEP-induced GM-CSF release requires endocytosis of the particles, which Boland et al. (6) have previously demonstrated, we examined the influence of Cyto D, an inhibitor of actin filament assembly. Figure 2 shows that the secretion of GM-CSF in the control cultures was only slightly affected by Cyto D. However, DEPs without Cyto D increased the release of GM-CSF to 151%, whereas in the presence of Cyto D, the increase with DEPs was only 78% compared with cultures treated with Cyto D alone.
To determine the respective role of the adsorbed organic compounds and the carbon core, we compared the effects of native DEPs, extracts of DEPs, extracted DEPs, and carbon black particles (Fig. 3) . Dichloromethane extracts of DEPs at 20 µg/ml, a concentration equivalent to 10 µg/cm 2 of native DEPs, had the same effect on GM-CSF release as unextracted DEPs (172 and 191%, respectively, over control values). However, the extracted particles induced a lower but still significant increase in GM-CSF release, whereas carbon black particles had no effect (73 and 3%, respectively, over control values).
DEPs contain trace amounts of metals on the particle surface that may, like for particles such as asbestos or http://ajplung.physiology.org/ ROFA, mediate an inflammatory response through catalysis of redox reactions directly on the particle surface. Figure 4 shows, however, that the metal chelator DEF did not alter the inflammatory response to DEPs.
To investigate the molecular events leading to the increase in GM-CSF secretion, we first studied the effects of the protein synthesis inhibitor cycloheximide and the RNA synthesis inhibitor actinomycin D. Both inhibitors blocked DEP-induced GM-CSF release, suggesting that de novo protein and mRNA syntheses are necessary in mediating the DEP effect (Table 1) . Measurement of mRNA levels by RT-PCR corroborates these results (Fig. 5) . Indeed, a treatment for 24 h with DEPs at 10 µg/cm 2 increased the mRNA of GM-CSF compared with that of the control cultures. Carbon black particles also induced an increase in this mRNA, which is, however, less important than after DEP treatment. Transcription factors such as NF-B, which has been shown to be activated by DEPs (3, 36) , are sensitive to oxidative stress. To investigate whether the DEP-induced increase in GM-CSF involves ROS, various radical scavengers were added to the cell cultures. Figure 6 shows the decrease in the response to DEPs after the addition of NAC (43% over control value compared with 151% without drug), DMTU (40% over control value compared with 151% without drug), and PDTC (96% over control value compared with 213% without drug). However, the lipid radical scavenger ␣-tocopherol had no effect on GM-CSF release after DEP treatment (174% over control value compared with 133% without drug). No decrease in GM-CSF release was observed in control cultures by these radical scavengers. Furthermore, Fig. 7 shows that in the presence of NAC, the increase in GM-CSF release was not only significantly reduced in cultures treated with native DEPs but also in cultures treated with DEP extracts.
To assess the signal transduction pathways involved in DEP-induced GM-CSF release, we used specific inhibitors. H-89, an inhibitor of protein kinase (PK) A, as well as the PKC inhibitor GF-109203X had no effect on the secretion of GM-CSF in response to DEP treatment. Furthermore, inhibitors of the cyclooxygenase and lipoxygenase pathways (indomethacin and nordihydroguaiaretic acid, respectively) did not reduce the secretion of GM-CSF (Table 2 ). In contrast, the tyrosine kinase inhibitor genistein diminished the release of GM-CSF in the control cultures and blocked the increase in cytokine secretion after DEP treatment (Fig.  8) . In addition, we studied the effect of specific inhibitors of the mitogen-activated protein (MAP) kinase pathways. PD-98059, an inhibitor of MAP or ERK kinase, diminished the release of GM-CSF in control cultures and strongly reduced the DEP-induced increase in GM-CSF secretion (58% over control value compared with 213% without drug), whereas the MAP kinase p38 inhibitor SB-203580 had a lower effect (102% over control value; Fig. 8 ). Western blot analysis actually showed an increase in phosporylated ERK, which is the active form of MAP kinase, after only 30 min of exposure to DEPs (Fig. 9) .
DISCUSSION
Exposure of animals or humans to DEPs results in an inflammatory reaction characterized by enhanced IgE and cytokine production (24) . Airway epithelial cells exposed to DEPs in vitro have been shown to secrete Values are means Ϯ SE in pg/ml; n ϭ 3 cultures. DEP, diesel exhaust particle; GM-CSF, granulocyte-macrophage colony-stimulating factor; CHX, cycloheximide; Act D, actinomycin D. Significantly different (P Ͻ 0.05, corrected for multiple comparisons) compared with: * control with and without inhibitor; † DEP alone. increased amounts of proinflammatory mediators such as soluble intercellular adhesion molecule-1 (sICAM-1), IL-6, IL-8, and GM-CSF (5, 6, 25, 33) . However, the underlying cellular mechanisms of this inflammatory response are still unclear. In the present study, we studied the mechanisms that induce GM-CSF secretion after DEP exposure in the human bronchial epithelial cell line 16HBE14oϪ. GM-CSF is a key cytokine in the development of respiratory allergic disease because besides its role in the maturation of granulocytes and macrophages, it also has several biological activities on eosinophils, the predominant cells in bronchial asthma. There is an increase in GM-CSF-positive cells in bronchial asthma (18) , and the nasal epithelial cells of atopic individuals release increased amounts of GM-CSF that were still enhanced by allergen exposure (8) . Experimental studies have indicated an increased release in GM-CSF by human bronchial epithelial cells from asthmatic patients (16) , who also present an increased sensitivity to DEPs in respect to GM-CSF release (4) . The increase in inflammatory mediators could be due to the release of preexisting pools of cytokines or to de novo protein synthesis involving enhanced translation of preexisting mRNA or increased transcription of cytokine genes. These mechanisms may involve signal transduction pathways using PKs and/or ROS. In addition, it is unclear which part of the particle, the adsorbed organic compounds, the metals, and/or the carbon core, is responsible for the inflammatory response and if it requires phagocytosis of the particles.
We have demonstrated that DEPs induce a time-and dose-dependent increase in the secretion of GM-CSF by 16HBE14oϪ cells, which corroborates results from primary cultures of human nasal or bronchial epithelial cells (5, 25) .
Phagocytosis of DEPs observed in airway epithelial cells (7), which is also a time-and dose-dependent process (6), seems to be a prerequisite for the induction of cytokine release because Cyto D, an inhibitor of actin filament polymerization involved in the endocytosis of particles, reduced DEP-induced GM-CSF secretion. An inhibitory effect of particle-induced cytokine release by Cyto D was also seen for asbestos (29) . The concentration of Cyto D used in this study only partially inhibits the phagocytosis of DEPs as seen by flow cytometry and transmission electron microscopy (data not shown), which may explain that DEPs still significantly increase the release of GM-CSF despite the presence of Cyto D. Exocytosis, which also depends, in part, on actin filament assembly, was not affected by Cyto D treatment because the release of GM-CSF was only slightly reduced in control cultures in the presence of Cyto D.
A crucial question for understanding the inflammatory response generated by DEPs is the relative importance of the carbon core and the adsorbed organic or metallic compounds in this event. The DEP-induced GM-CSF increase is not inhibited by the metal chelator DEF, suggesting that the trace amounts of metals on the DEP surface are not responsible for the inflammatory effect, in contrast to other air pollution particles such as ROFA (27) . Furthermore, we have shown that the increased release of GM-CSF is mainly due to the adsorbed organic compounds because organic extracts of DEPs induce the same response as DEPs. In this connection, Ohtoshi et al. (25) have shown that benzo-[a]pyrene, an aromatic hydrocarbon contained in DEPs, increases the release of GM-CSF by the human bronchial cell line BEAS-2B. This corroborates previous results by Boland et al. (6) on the effect of catalysts that reduce the adsorbed organic compounds, thus decreasing the DEP-induced GM-CSF secretion. A predominant role of the adsorbed organic compounds on DEPinduced cytokine release has also been shown for rat alveolar macrophages (41) . However, the carbon core may also play a role in the inflammatory response because extracted DEPs have a lower but still significant effect. The differences in response between the carbon core of DEPs and carbon black, which had no effect on GM-CSF release, may be due to different particle number, size, or surface area. Indeed, different types of carbon black particles at the same concentration could have adverse biological effects depending on their physical properties (12) . Recently, it has been shown that ultrafine carbon black exhibits greater free radical activity than fine carbon black or quartz (34) . This points out the difficulty in predicting the role of the carbon core by the use of other kinds of particles devoid of organic compounds like carbon black, TiO 2 , or silica. However, because the inflammatory response elicited is a time-and dose-dependent process, carbon black particles may induce an increase in GM-CSF at another time point or at higher concentrations.
Our hypothesis is that phagocytosis may be necessary to allow the desorption and further metabolism of the adsorbed organic compounds. DEPs and their extracts both seem to trigger signal transduction pathways involving ROS because the secretion of GM-CSF is strongly decreased after treatment with NAC. Indeed, polycyclic aromatic hydrocarbons such as benzo-[a]pyrene and 1-nitropyrene (23, 35) as well as the activation of cytochrome P-450 have been shown to induce the production of ROS. We have shown that the increase in GM-CSF after DEP treatment is inhibited by the radical scavengers NAC, DMTU, and PDTC. However, no increase in the intracellular levels of peroxides or depletion of thiols could be observed by flow cytometry with fluorescent probes (data not shown). This suggests that DEPs did induce signaling pathways involving a moderate production of ROS, which act as a second messenger leading to the production of inflammatory mediators, whereas oxidative stress due to high levels of ROS has been shown to induce cytotoxicity. However, in acellular systems, DEPs or DEP extracts could produce ROS (31, 38). Furthermore, the lipid radical scavenger ␣-tocopherol had no effect, suggesting that the inflammatory effect of DEPs is not due to lipid peroxidation, which has been shown to be involved in asbestos-induced transcription factor activation (15) .
We confirm the results of Ohtoshi et al. (25) showing that the release of GM-CSF seems to be due to de novo protein synthesis. This increase in synthesis seems rather to be due to new transcription of cytokine genes than to translation of preexisting mRNA because we showed an increase in GM-CSF mRNA by DEPs. Exposure of bronchial epithelial cells to DEPs has also been shown to increase transcription of IL-8 mRNA (36) . This is in agreement with previous results (3) of increased activation of the transcription factor NF-B by DEPs in 16HBE14oϪ cells. The production of ROS by DEPs may explain the activation of this oxidative stress-sensitive transcription factor.
To further investigate the signaling pathway elicited by DEPs, we used different specific inhibitors of several PKs. Only genistein, an inhibitor of tyrosine kinases, but not inhibitors of PKC, PKA, or the arachidonic acid pathway prevents the effect of DEPs, whereas they are involved in GM-CSF release induced by other mediators (2, 17, 26) . Genistein also reduces the release of GM-CSF in control cultures, suggesting that the same signaling pathways are involved in constitutive and DEP-induced GM-CSF release. 9 . Effect of DEP exposure on extracellular signal-regulated kinase (ERK) 1 and ERK2 phosphorylation (P-ERK1 and P-ERK2, respectively) in human bronchial epithelial cells (16HBE14oϪ) as measured by Western blotting. Cells were exposed to particles at 10 µg/cm 2 for indicated treatment times. Blots with a specific antibody to phosphorylated tyrosine of ERK (top) were stripped and reprobed with an ERK-specific antibody to show amounts of ERK blotted (bottom).
Tyrosine kinases are known to elicit MAP kinase pathways that lead to phosphorylation-dependent activation of a variety of transcription factors that modulate cytokine gene expression. ERK, c-Jun NH 2 -terminal kinase, and the p38 pathway are the three major MAP kinase pathways. Indeed PD-98059, an inhibitor of the ERK pathway, also significantly reduces the release of GM-CSF in response to DEPs, whereas the inhibitor of p38 MAP kinase (SB-203580) has a lower effect. However, PD-98059 is also an antagonist of the aryl hydrocarbon receptor involved in the expression of phase I and II biotransforming enzymes (28) , and thus we cannot exclude that its inhibitory action could also be due to the inhibition of DEP metabolism. However, we have shown that DEP treatment actually increases the active, phosphorylated form of ERK. Recently, MAP kinases have been shown to be activated by metals that also induce the expression of cytokines in the human bronchial epithelial cell line BEAS-2B (32) . Cytokine induction in alveolar macrophages has been shown to be dependent on both the ERK and p38 kinase pathways for optimal gene expression (9) . MAP kinase pathways are involved in the activation of the transcription factor NF-B, which is also induced by DEPs (3) . Other cytokines such as IL-1 could also activate these signaling pathways and increase the secretion of GM-CSF. Thus the DEPinduced GM-CSF release, which is observed after 24 h, may be secondary to an autocrine effect. Indeed, Boland et al. (6) have shown an increase in IL-1␤ release by human airway epithelial cells after DEP treatment.
In conclusion, the present study shows that the increase in GM-CSF release by DEPs is mainly due to the adsorbed organic compounds that may be metabolized after phagocytosis of the particles and induce the production of ROS. Our results further suggest that tyrosine kinase(s) may be involved in the DEPtriggered signaling of the GM-CSF response. These results are of particular interest regarding the development of efficient exhaust gas posttreatments that may reduce the inflammatory response elicited by DEP exposure, which is especially important for asthmatic patients. Indeed oxidation catalysts that reduce the soluble organic fraction are under development, and it has been shown that the use of these catalysts reduces the release of GM-CSF by human epithelial cells after DEP exposure (6) .
